Aroa Research Development vs Interest Income Analysis

ARX Stock

0.80 0.05 6.67%

Aroa Biosurgery financial indicator trend analysis is way more than just evaluating Aroa Biosurgery prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Aroa Biosurgery is a good investment. Please check the relationship between Aroa Biosurgery Research Development and its Interest Income accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aroa Biosurgery. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Research Development vs Interest Income

Research Development vs Interest Income Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Aroa Biosurgery Research Development account and Interest Income. At this time, the significance of the direction appears to have very strong relationship.

The correlation between Aroa Biosurgery's Research Development and Interest Income is 0.85. Overlapping area represents the amount of variation of Research Development that can explain the historical movement of Interest Income in the same time period over historical financial statements of Aroa Biosurgery, assuming nothing else is changed. The correlation between historical values of Aroa Biosurgery's Research Development and Interest Income is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Research Development of Aroa Biosurgery are associated (or correlated) with its Interest Income. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Interest Income has no effect on the direction of Research Development i.e., Aroa Biosurgery's Research Development and Interest Income go up and down completely randomly.

Correlation Coefficient

0.85

Relationship Direction	Positive
Relationship Strength	Strong

View All Relationships

Research Development

Interest Income

Income earned from the investment of cash or from lending money to others, including interest from bank accounts, bonds, or other interest-bearing investments.

Most indicators from Aroa Biosurgery's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Aroa Biosurgery current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aroa Biosurgery. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Tax Provision is likely to gain to about 222.6 K in 2025, whereas Selling General Administrative is likely to drop slightly above 652.9 K in 2025.

	2022	2023	2024	2025 (projected)
Depreciation And Amortization	3.5M	4.0M	4.6M	2.9M
Interest Income	2.7M	1.7M	1.9M	1.1M

Depreciation And Amortization Interest Income

Aroa Biosurgery fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Accounts Payable	Cash	Other Assets	Net Receivables	Short Term Investments	Other Current Assets	Total Liab	Common Stock	Property Plant Equipment	Net Tangible Assets	Retained Earnings	Other Stockholder Equity	Total Current Assets	Intangible Assets	Short Long Term Debt Total	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments
Total Assets		0.59	0.62	0.99	-0.2	0.7	0.43	-0.58	0.92	0.77	0.73	0.6	0.1	0.87	0.86	0.65	-0.91	0.99	0.33	0.71	0.9	-0.93	-0.27	0.95	0.94	0.91
Other Current Liab	0.59		0.87	0.5	-0.21	0.83	0.31	-0.75	0.54	0.4	0.4	0.76	-0.48	0.45	0.45	0.48	-0.55	0.54	0.12	0.33	0.52	-0.63	-0.11	0.63	0.62	0.44
Total Current Liabilities	0.62	0.87		0.53	-0.18	0.72	0.57	-0.55	0.49	0.31	0.35	0.79	-0.46	0.49	0.45	0.56	-0.64	0.58	0.13	0.63	0.52	-0.7	-0.37	0.65	0.7	0.54
Total Stockholder Equity	0.99	0.5	0.53		-0.24	0.66	0.37	-0.49	0.92	0.81	0.73	0.47	0.24	0.89	0.9	0.55	-0.86	0.99	0.27	0.68	0.91	-0.88	-0.21	0.92	0.9	0.91
Other Liab	-0.2	-0.21	-0.18	-0.24		-0.05	-0.13	-0.26	-0.14	-0.16	-0.08	0.08	-0.52	-0.17	-0.19	0.36	-0.1	-0.17	0.29	-0.19	-0.19	0.25	0.1	-0.24	-0.25	-0.21
Accounts Payable	0.7	0.83	0.72	0.66	-0.05		0.37	-0.68	0.59	0.6	0.68	0.56	-0.24	0.67	0.59	0.48	-0.66	0.7	0.11	0.44	0.71	-0.61	-0.14	0.67	0.62	0.65
Cash	0.43	0.31	0.57	0.37	-0.13	0.37		-0.25	0.18	-0.04	0.32	0.58	-0.2	0.26	0.02	0.48	-0.52	0.44	0.22	0.9	0.24	-0.56	-0.96	0.44	0.57	0.57
Other Assets	-0.58	-0.75	-0.55	-0.49	-0.26	-0.68	-0.25		-0.61	-0.4	-0.3	-0.73	0.56	-0.35	-0.37	-0.68	0.68	-0.55	-0.41	-0.27	-0.43	0.57	0.14	-0.57	-0.56	-0.44
Net Receivables	0.92	0.54	0.49	0.92	-0.14	0.59	0.18	-0.61		0.69	0.57	0.45	0.15	0.8	0.91	0.51	-0.78	0.9	0.29	0.5	0.88	-0.79	-0.04	0.87	0.8	0.7
Short Term Investments	0.77	0.4	0.31	0.81	-0.16	0.6	-0.04	-0.4	0.69		0.58	0.23	0.26	0.77	0.83	0.4	-0.69	0.81	0.12	0.28	0.74	-0.64	0.21	0.68	0.65	0.79
Other Current Assets	0.73	0.4	0.35	0.73	-0.08	0.68	0.32	-0.3	0.57	0.58		0.41	0.11	0.76	0.59	0.49	-0.62	0.74	0.26	0.5	0.72	-0.65	-0.21	0.7	0.66	0.68
Total Liab	0.6	0.76	0.79	0.47	0.08	0.56	0.58	-0.73	0.45	0.23	0.41		-0.64	0.42	0.24	0.88	-0.75	0.55	0.47	0.58	0.41	-0.78	-0.48	0.69	0.76	0.51
Common Stock	0.1	-0.48	-0.46	0.24	-0.52	-0.24	-0.2	0.56	0.15	0.26	0.11	-0.64		0.28	0.31	-0.49	0.17	0.14	-0.24	0.0	0.27	0.05	0.17	0.06	-0.03	0.14
Property Plant Equipment	0.87	0.45	0.49	0.89	-0.17	0.67	0.26	-0.35	0.8	0.77	0.76	0.42	0.28		0.85	0.54	-0.78	0.88	0.27	0.56	0.97	-0.8	-0.08	0.9	0.81	0.79
Net Tangible Assets	0.86	0.45	0.45	0.9	-0.19	0.59	0.02	-0.37	0.91	0.83	0.59	0.24	0.31	0.85		0.34	-0.69	0.86	0.11	0.41	0.9	-0.68	0.17	0.78	0.7	0.71
Retained Earnings	0.65	0.48	0.56	0.55	0.36	0.48	0.48	-0.68	0.51	0.4	0.49	0.88	-0.49	0.54	0.34		-0.87	0.64	0.6	0.57	0.49	-0.77	-0.4	0.7	0.77	0.62
Other Stockholder Equity	-0.91	-0.55	-0.64	-0.86	-0.1	-0.66	-0.52	0.68	-0.78	-0.69	-0.62	-0.75	0.17	-0.78	-0.69	-0.87		-0.92	-0.43	-0.73	-0.76	0.92	0.37	-0.88	-0.92	-0.89
Total Current Assets	0.99	0.54	0.58	0.99	-0.17	0.7	0.44	-0.55	0.9	0.81	0.74	0.55	0.14	0.88	0.86	0.64	-0.92		0.32	0.72	0.89	-0.91	-0.28	0.93	0.93	0.94
Intangible Assets	0.33	0.12	0.13	0.27	0.29	0.11	0.22	-0.41	0.29	0.12	0.26	0.47	-0.24	0.27	0.11	0.6	-0.43	0.32		0.3	0.24	-0.42	-0.28	0.39	0.41	0.28
Short Long Term Debt Total	0.71	0.33	0.63	0.68	-0.19	0.44	0.9	-0.27	0.5	0.28	0.5	0.58	0.0	0.56	0.41	0.57	-0.73	0.72	0.3		0.54	-0.77	-0.82	0.69	0.79	0.8
Property Plant And Equipment Net	0.9	0.52	0.52	0.91	-0.19	0.71	0.24	-0.43	0.88	0.74	0.72	0.41	0.27	0.97	0.9	0.49	-0.76	0.89	0.24	0.54		-0.79	-0.05	0.92	0.8	0.75
Current Deferred Revenue	-0.93	-0.63	-0.7	-0.88	0.25	-0.61	-0.56	0.57	-0.79	-0.64	-0.65	-0.78	0.05	-0.8	-0.68	-0.77	0.92	-0.91	-0.42	-0.77	-0.79		0.43	-0.96	-1.0	-0.87
Net Debt	-0.27	-0.11	-0.37	-0.21	0.1	-0.14	-0.96	0.14	-0.04	0.21	-0.21	-0.48	0.17	-0.08	0.17	-0.4	0.37	-0.28	-0.28	-0.82	-0.05	0.43		-0.29	-0.43	-0.42
Non Current Assets Total	0.95	0.63	0.65	0.92	-0.24	0.67	0.44	-0.57	0.87	0.68	0.7	0.69	0.06	0.9	0.78	0.7	-0.88	0.93	0.39	0.69	0.92	-0.96	-0.29		0.96	0.83
Non Currrent Assets Other	0.94	0.62	0.7	0.9	-0.25	0.62	0.57	-0.56	0.8	0.65	0.66	0.76	-0.03	0.81	0.7	0.77	-0.92	0.93	0.41	0.79	0.8	-1.0	-0.43	0.96		0.89
Cash And Short Term Investments	0.91	0.44	0.54	0.91	-0.21	0.65	0.57	-0.44	0.7	0.79	0.68	0.51	0.14	0.79	0.71	0.62	-0.89	0.94	0.28	0.8	0.75	-0.87	-0.42	0.83	0.89

Click cells to compare fundamentals

Aroa Biosurgery Account Relationship Matchups

Aroa Biosurgery fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	73.1M	104.7M	109.1M	101.9M	117.2M	123.0M
Other Current Liab	3.7M	4.5M	5.1M	6.2M	5.6M	5.0M
Total Current Liabilities	14.0M	6.2M	7.4M	8.7M	7.9M	8.1M
Total Stockholder Equity	53.7M	93.4M	95.4M	87.1M	100.1M	105.1M
Other Liab	154K	158K	161K	164K	147.6K	140.2K
Accounts Payable	679.3K	1.2M	1.8M	1.6M	1.4M	853.8K
Cash	32.5M	5.7M	8.9M	10.6M	12.2M	8.2M
Net Receivables	6.6M	16.0M	13.4M	24.1M	27.7M	29.1M
Short Term Investments	1.5M	47.6M	34.1M	17.2M	19.7M	20.7M
Other Current Assets	907.0K	1.2M	10.4M	4.1M	3.7M	3.6M
Total Liab	19.4M	11.3M	13.7M	14.8M	13.3M	13.8M
Common Stock	89.3M	135.5M	137.1M	134.6M	154.8M	108.9M
Property Plant Equipment	8.7M	12.7M	15.4M	20.6M	18.6M	10.5M
Net Tangible Assets	(11.5M)	40.4M	83.2M	85.6M	98.4M	103.4M
Retained Earnings	(39.2M)	(47.5M)	(48.2M)	(57.0M)	(65.5M)	(68.8M)
Other Stockholder Equity	(0.22)	(489.4K)	(0.03)	(24.8K)	(22.4K)	(21.2K)
Total Current Assets	44.8M	74.2M	73.1M	63.3M	72.8M	76.5M
Intangible Assets	11.5M	10.9M	11.3M	13.0M	14.9M	12.6M
Short Long Term Debt Total	15.4M	5.8M	7.1M	6.8M	7.8M	8.2M
Property Plant And Equipment Net	11.6M	14.3M	19.3M	20.4M	23.4M	13.4M
Net Debt	(17.6M)	(268.6K)	(2.3M)	(3.7M)	(4.3M)	(4.5M)
Non Current Assets Total	28.4M	30.5M	35.9M	38.5M	44.3M	30.1M
Non Currrent Assets Other	157.0K	138.5K	117.9K	90.8K	104.4K	109.6K
Cash And Short Term Investments	33.9M	53.4M	43.0M	27.7M	31.9M	32.7M
Good Will	5.1M	5.1M	5.2M	5.1M	4.6M	4.2M
Common Stock Shares Outstanding	300.4M	342.2M	342.9M	343.8M	395.4M	350.4M
Long Term Debt Total	3.0M	5.7M	5.3M	6.5M	7.5M	4.1M
Liabilities And Stockholders Equity	73.1M	104.7M	109.1M	101.9M	117.2M	82.3M
Non Current Liabilities Total	5.4M	5.1M	6.3M	6.1M	5.5M	7.5M
Inventory	3.3M	3.7M	4.5M	7.4M	8.5M	9.0M
Accumulated Other Comprehensive Income	3.6M	5.5M	6.5M	9.4M	10.9M	11.4M
Short Term Debt	9.7M	547.4K	523.3K	920.9K	1.1M	1.0M
Capital Lease Obligations	5.8M	5.5M	6.7M	6.8M	7.8M	5.9M
Net Invested Capital	62.8M	93.4M	95.4M	87.1M	100.2M	91.1M
Property Plant And Equipment Gross	17.3M	20.8M	27.6M	30.5M	35.1M	23.0M
Capital Stock	89.3M	135.5M	137.1M	134.7M	154.9M	130.0M
Net Working Capital	30.7M	68.0M	65.7M	54.6M	62.8M	59.0M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Aroa Stock Analysis

When running Aroa Biosurgery's price analysis, check to measure Aroa Biosurgery's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aroa Biosurgery is operating at the current time. Most of Aroa Biosurgery's value examination focuses on studying past and present price action to predict the probability of Aroa Biosurgery's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aroa Biosurgery's price. Additionally, you may evaluate how the addition of Aroa Biosurgery to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC